Insider Sales at Cerus Corp: Clinical Impact, FDA Approval, and Investor Insight
Insightful review of Cerus Corp’s insider sales, clinical validation, FDA clearance and market outlook for its pathogen‑inactivation platelet system.
4 minutes to read
Cerus Corp
Insider Buying at Cerus Signals Confidence Amid Market Volatility
Insider buying at Cerus Corp signals leadership confidence amid market swings, spotlighting the company’s pathogen‑inactivation tech, growing reimbursement prospects, and potential upside for investors.
4 minutes to read